Sort by
Refine Your Search
-
Professor Camille Carroll on the EJS ACT-PD trial. Identifying a disease-modifying therapy (DMT) for Parkinson’s disease (PD) is a major unmet need. The Edmond J Safra Accelerating Clinical Trials in
Enter an email to receive alerts for acceleration-"https:" positions